Ryan G.
About Ryan G.
Ryan G. serves as the Regional Account Manager for Alagille Syndrome at Mirum Pharmaceuticals, where he has worked since 2021. He has extensive experience in the pharmaceutical industry, focusing on rare diseases and engaging with patient advocacy groups to raise awareness for Livmarli (Maralixibat).
Work at Mirum Pharmaceuticals
Ryan G. has served as the Regional Account Manager for Alagille Syndrome (ALGS) at Mirum Pharmaceuticals since 2021. In this role, he is responsible for managing accounts across Northern California, Nevada, Oregon, Washington, Hawaii, and Alaska. He focuses on enhancing awareness and education around Livmarli (Maralixibat), a treatment for Alagille Syndrome, by aligning with regional patient and caregiver advocacy groups. His efforts include launching disease education initiatives and account profiling for the condition.
Previous Experience in Rare Disease Management
Before joining Mirum Pharmaceuticals, Ryan G. worked at Sanofi Genzyme as a Senior Area Business Manager in Rare Hematology from 2020 to 2021. He also held the position of Regional Account Manager for Lysosomal Acid Lipase Deficiency (LAL-D) at Alexion Pharmaceuticals from 2016 to 2020. His background includes roles at Gilead Sciences and Regeneron Pharmaceuticals, where he developed Key Opinion Leaders (KOLs) to enhance corporate engagement and brand building in the rare disease space.
Education and Expertise
Ryan G. earned a Bachelor of Science degree in Business, Management, Marketing, and Related Support Services from California State University-Sacramento, completing his studies from 1999 to 2003. His educational background supports his extensive experience in the pharmaceutical industry, particularly in managing complex rare diseases and engaging with healthcare providers and KOLs.
Clinical Acumen and Advocacy
Ryan G. possesses strong clinical acumen that enables him to educate healthcare providers on complex rare diseases. His expertise is particularly valuable in situations that require engagement with KOLs and assisting families on their diagnostic journeys. He has played a significant role in improving awareness for Livmarli (Maralixibat) and understanding the multi-organ manifestations of Alagille Syndrome due to JAG1 and NOTCH2 mutations.
Career Progression in Pharmaceuticals
Ryan G. has a diverse career in the pharmaceutical industry, beginning as a Professional Healthcare Representative at Pfizer from 2003 to 2008. He progressed through various roles, including Cardiovascular Specialty Representative at Daiichi Sankyo and Therapeutic Specialist at Gilead Sciences. His career reflects a consistent focus on rare diseases and specialty pharmaceuticals, contributing to his comprehensive understanding of the market and patient needs.